Decreased pulmonary drug metabolism in mice treated with the PCB metabolite 4-methylsulphonyl-2,2',5,5'-tetrachlorobiphenyl

Toxicol Lett. 1986 Sep;32(3):261-7. doi: 10.1016/0378-4274(86)90117-7.

Abstract

4-Methylsulphonyl-2,2',5,5'-tetrachlorobiphenyl (4-MeSO2-TCB) is a major polychlorinated biphenyl (PCB) metabolite present in lung tissue of PCB-exposed human subjects. After treatment of mice with 4-MeSO2-TCB (100 mg/kg), the pulmonary N-demethylation of aminopyrine in vitro was significantly decreased, while hepatic N-demethylation was concomitantly increased, as compared to tissue from control mice. Treatment of mice with 4-MeSO2-TCB also decreased the in vivo pulmonary covalent binding of o,p'-DDD, while the in vivo hepatic covalent binding was increased. The results indicate that 4-MeSO2-TCB inhibits or represses a cytochrome P-450-dependent enzyme activity in the mouse lung, while in contrast this activity is induced in the mouse liver.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminopyrine / metabolism
  • Animals
  • Binding, Competitive / drug effects
  • Cytochrome P-450 Enzyme Inhibitors
  • Female
  • Liver / drug effects*
  • Liver / metabolism
  • Lung / drug effects*
  • Lung / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mitotane / metabolism
  • Polychlorinated Biphenyls / toxicity*

Substances

  • Cytochrome P-450 Enzyme Inhibitors
  • Aminopyrine
  • 4-methylsulfonyl-2,2',5,5'-tetrachlorobiphenyl
  • Mitotane
  • Polychlorinated Biphenyls